Travere Therapeutics, Inc. TVTX Business Segments — Cost of goods sold

Similar metrics at other companies

POWLReportable Segment — Cost of goods sold

$208.68M+6.9%

INDVReportable Segment — Cost of Sales

$40M-9.1%

MSMReportable Segment — Cost of goods sold

$540.19M+2.6%

CHWYReportable Segment — Cost of goods sold

$2.35B+7.0%

WMSReportable Segment — Cost of goods sold

$393.4M-4.6%

EXELReportable Segment — Cost of goods sold

$19.95M+4.1%

Questions, answered.

What is Travere Therapeutics, Inc.'s business segments — cost of goods sold?

Travere Therapeutics, Inc. (TVTX) reported business segments — cost of goods sold of $1.95M in Q1 2026.

How has Travere Therapeutics, Inc.'s business segments — cost of goods sold changed year-over-year?

Travere Therapeutics, Inc.'s business segments — cost of goods sold decreased by 58.3% year-over-year, from $4.68M to $1.95M.

What is the long-term trend for Travere Therapeutics, Inc.'s business segments — cost of goods sold?

Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s business segments — cost of goods sold has grown at a 32.7% compound annual growth rate (CAGR), from $4.42M to $10.34M.

What does business segments — cost of goods sold mean?

This metric captures the direct costs attributable to the production and distribution of the company's therapeutic products. It reflects the efficiency of the supply chain and manufacturing processes relative to the revenue generated.